PO.CL01.14 · 临床研究
利用InSituPlex®和ZEISS Axioscan 7实现精简的高重成像用于空间表型分析
Streamlined high-plex imaging with InSituPlex®and ZEISS Axioscan 7 for spatial phenotyping
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
多重免疫荧光(mIF)为在空间背景下可视化复杂的生物标志物特征提供了强大的手段。然而,大多数高重mIF方法依赖于反复的染色和成像循环,这带来了工作流程的复杂性,并需要劳动密集的手工操作或能够自动化这些多步骤程序的精密仪器。Vizgen的InSituPlex检测支持在单次染色步骤中快速、多重地检测多达12种蛋白生物标志物,利用信号放大,使用标准荧光滤光片配置即可实现对高丰度和低表达靶标的稳健检测。当与Axioscan 7空间生物学平台(专为完全自动化、高通量的载玻片扫描并具备额外荧光通道而设计)结合使用时,该工作流程无需光谱解混即可实现更高重、单轮的成像。在此,我们展示了这一整合方法在简化检测开发、扩展生物标志物panel设计灵活性以及提供高效、可扩展的多重蛋白成像方面的能力。我们开发了新一代InSituPlex®检测,以利用Axioscan 7空间生物学系统增加标志物的同时检测数量。我们精心选择了一组荧光团,以最小化光谱重叠并最大化检测特异性,确保所有荧光通道清晰区分而无需光谱解混来分离信号。信号质量采用STARVUE图像分析流程进行分析,精确测定了阳性细胞信号的强度和密度。荧光团数量的增加显示出优异的信噪比,且荧光通道之间无串扰。InSituPlex检测扩展的通道容量在增加可在肿瘤样本中同时检测的生物标志物数量的同时,实现了简化的工作流程。这一能力进一步增强了InSituPlex panel设计的灵活性并精简了检测开发流程。新型InSituPlex荧光染料panel与Axioscan 7空间生物学平台的整合,提供了卓越的高通量mIF工作流程。这一组合利用两种技术已确立的重现性和通量,在实现更高重成像的同时显著减少了手工步骤。我们预期这一整合平台将赋能研究人员揭示对癌症及其复杂环境更深入、高分辨率的空间洞见。
查看英文原文 English abstract
Multiplex immunofluorescence (mIF) provides a powerful means to visualize complex biomarker signatures with spatial context. Yet, most high-plex mIF approaches depend on repeated cycles of staining and imaging, which introduce workflow complexity and necessitate either labor-intensive manual handling or sophisticated instrumentation capable of automating these multistep procedures. Vizgen's InSituPlex assay supports rapid, multiplexed detection of up to 12 protein biomarkers in a single staining step, leveraging signal amplification to achieve robust detection of both abundant and lowly expressed targets using standard fluorescence filter configurations. When combined with the Axioscan 7 spatial biology platform, engineered for fully automated, high-throughput slide scanning with additional fluorescent channels, this workflow enables higher-plex, single-round imaging without the need for spectral unmixing. Here, we demonstrate the power of this integrated approach to streamline assay development, expand biomarker panel design flexibility, and deliver efficient, scalable multiplexed protein imaging. A next generation InSituPlex® assay was developed to increase the simultaneous detection of markers using the Axioscan 7 spatial biology system. A panel of fluorophores was carefully selected to minimize spectral overlap and maximize detection specificity, ensuring clear distinction of all fluorescent channels without requiring spectral unmixing to deconvolute signals. Signal quality was analyzed using the STARVUE image analysis pipeline which precisely determined positive cell signal intensity and density. The increased number of fluorophores showed excellent signal to noise ratio and no crosstalk between fluorescent channels. The expanded channel capacity of InSituPlex assay allows for a simplified workflow while increasing the number of biomarkers that can simultaneously be detected in tumor samples. This capability further enhances flexibility for InSituPlex panel design and streamlines the assay development process. The integration of the novel InSituPlex fluorescent dye panel and the Axioscan 7 spatial biology platform delivers a superior, high throughput mIF workflow. This combination enables higher-plex imaging while significantly reducing manual steps, leveraging the established reproducibility and throughput of both technologies. We anticipate this integrated platform will empower researchers to unlock deeper, high resolution spatial insights into cancers and their complex environments.
利益披露 Disclosure
K. Hwang, None..
M. Woerdemann, None..
L. Loetgering, None..
M. Widmaier, None..
S. Derakhshani, None..
J. He, None..
A. Vasaturo, None.